Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexa B Schrock

Showing results (51-60 of 130) with videos related to

Pageof 13
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2022
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate CancerUmang Swami, Ryon P Graf, Roberto H Nussenzveig, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 16, 2017
ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non-Small Cell Lung CancerJessica J Lin, Lauren L Ritterhouse, Siraj M Ali, et al.
Pediatric Blood & Cancer|January 19, 2017
Identification of NTRK fusions in pediatric mesenchymal tumorsDean Pavlick, Alexa B Schrock, Denise Malicki, et al.
The Oncologist|June 29, 2019
<i>FGFR2</i>-Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic LandscapeSamuel J Klempner, Russell Madison, Vivek Pujara, et al.
JCO Precision Oncology|May 14, 2026
Genomics of <i>MTAP</i> Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling PlatformsDean C Pavlick, Shruthi Rengarajan, Jessica K Lee, et al.
The Oncologist|October 31, 2018
Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from TherapyHyunseok Kang, Dean Pettinga, Adrian D Schubert, et al.
JCO Precision Oncology|November 22, 2023
Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic <i>BRCA1</i>/<i>2</i>, Germline <i>PALB2</i>, or Homologous Recombination Deficiency SignatureFelipe Batalini, Russell W Madison, Ethan S Sokol, et al.
Oncology|September 23, 2020
Characterization of Clinical Cases of Malignant PEComa via Comprehensive Genomic Profiling of DNA and RNASaranya Akumalla, Russell Madison, Douglas I Lin, et al.
Cancer Discovery|April 7, 2016
BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination TherapySamuel J Klempner, Bruce Gershenhorn, Phu Tran, et al.
JTO Clinical and Research Reports|September 30, 2021
The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung CancerBarbara J Gitlitz, Silvia Novello, Tiziana Vavalà, et al.
Pageof 13

Showing results (51-60 of 130) with videos related to

Sort By:
Pageof 13
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 11, 2022
SPOP Mutations as a Predictive Biomarker for Androgen Receptor Axis-Targeted Therapy in De Novo Metastatic Castration-Sensitive Prostate CancerUmang Swami, Ryon P Graf, Roberto H Nussenzveig, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|January 16, 2017
ROS1 Fusions Rarely Overlap with Other Oncogenic Drivers in Non-Small Cell Lung CancerJessica J Lin, Lauren L Ritterhouse, Siraj M Ali, et al.
Pediatric Blood & Cancer|January 19, 2017
Identification of NTRK fusions in pediatric mesenchymal tumorsDean Pavlick, Alexa B Schrock, Denise Malicki, et al.
The Oncologist|June 29, 2019
<i>FGFR2</i>-Altered Gastroesophageal Adenocarcinomas Are an Uncommon Clinicopathologic Entity with a Distinct Genomic LandscapeSamuel J Klempner, Russell Madison, Vivek Pujara, et al.
JCO Precision Oncology|May 14, 2026
Genomics of <i>MTAP</i> Loss in >500,000 Solid Tumor Specimens Profiled Using Comprehensive Genomic Profiling PlatformsDean C Pavlick, Shruthi Rengarajan, Jessica K Lee, et al.
The Oncologist|October 31, 2018
Genomic Profiling of Parathyroid Carcinoma Reveals Genomic Alterations Suggesting Benefit from TherapyHyunseok Kang, Dean Pettinga, Adrian D Schubert, et al.
JCO Precision Oncology|November 22, 2023
Homologous Recombination Deficiency Landscape of Breast Cancers and Real-World Effectiveness of Poly ADP-Ribose Polymerase Inhibitors in Patients With Somatic <i>BRCA1</i>/<i>2</i>, Germline <i>PALB2</i>, or Homologous Recombination Deficiency SignatureFelipe Batalini, Russell W Madison, Ethan S Sokol, et al.
Oncology|September 23, 2020
Characterization of Clinical Cases of Malignant PEComa via Comprehensive Genomic Profiling of DNA and RNASaranya Akumalla, Russell Madison, Douglas I Lin, et al.
Cancer Discovery|April 7, 2016
BRAFV600E Mutations in High-Grade Colorectal Neuroendocrine Tumors May Predict Responsiveness to BRAF-MEK Combination TherapySamuel J Klempner, Bruce Gershenhorn, Phu Tran, et al.
JTO Clinical and Research Reports|September 30, 2021
The Genomics of Young Lung Cancer: Comprehensive Tissue Genomic Analysis in Patients Under 40 With Lung CancerBarbara J Gitlitz, Silvia Novello, Tiziana Vavalà, et al.
Pageof 13